A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Incyte Corp.

About Incyte Corp.

Incyte has active internal drug discovery programs focused on the identification of novel small molecule drugs for inflammation, cancer and diabetes and they recently entered into a collaborative license agreement for Reverset™, a novel nucleoside analog reverse transcriptase inhibitor, which is in Phase II development to treat human immunodeficiency virus (HIV) infections.


Pieline for Incyte



Reverset -- HIV

CCR2 Antagonists -- Rheumatoid Arthritis, MS, Neuropathic Pain, Atherosclerosis

Sheddase Inhibitors -- Cancer



More on Incyte


Home Page

Key Statistics for Incyte

Basic Chart for Incyte

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.